Deep brain stimulation (DBS) was first introduced in 1987 to the developed world. As a developing country Malaysia begun its movement disorder program by doing ablation therapy using the Radionics system. Hospital Universiti Sains Malaysia a rural based teaching hospital had to take into consideration both health economics and outcomes in the area that it was providing neurosurgical care for when it initiated its Deep Brain Stimulation program. Most of the patients were from the low to medium social economic groups and could not afford payment for a DBS implant. We concentrated our DBS services to Parkinson's disease, Tourette's Syndrome and dystonia patients who had exhausted medical therapy. The case series of these patients and their follow-up are presented in this brief communication.
Introduction
Electrical stimulation of the central nervous system has been long utilised by humankind since the Roman and Greek civilisations (1) . In 43 AD, Scribonious Largus detailed in his book, 'Compositiones Medicamentorum', how the Romans used to treat headaches and gout with electric torpedo fish (2, 3) . However, it was not until much later in the 18th century that Galvani established through his experiments that the brain generates electrical impulses which spread down through the nerves and to the muscles (4) . Throughout the 19th century, scientists have experimented with electrical brain stimulation in animals, and, in 1874, Bartholow was the first to conduct and report findings of cerebral cortex stimulation in an awake patient (5 Patients undergoing DBS require a multidisciplinary team approach to management. Patients were assessed pre-operatively in accordance with local guidelines to ascertain the severity of their respective diseases. Appropriate scoring systems which will be discussed were used to assess patients and these included the United Parkinson's Disease Rating Score, Unified Dystonia Rating Scale, Fahn Marsden Dystonia Scale, Yale Global Tic Scoring Scale and Connors ADHD Score. Experienced neurosurgeons, neuroanaesthesiologists and neurologists were involved in the DBS procedures. Postoperatively, these patients were followed up closely in clinics to monitor their progression using the same pre-operative scoring system.
Patient characteristics
Twelve of our patients underwent DBS. Their age range was between 22 and 67 years. Ten of them were males and two were females. Out of the 12 patients, seven had a diagnosis of Idiopathic Parkinson's Disease (IPD), three were diagnosed with dystonia and two with Tourette's Syndrome. The demographic data of these patients can be seen in Table 1 Table 4 and Table 5 ). Pre-operatively, patients were assessed and scored both whilst on medications and off medications. Postoperatively, patients were scored whilst on medications at 3, 6, 12 and 24 months follow up. Both motor symptoms from the primary disease and secondary to medication side effects were evaluated. Four out of seven patients had at least a 50% improvement at 3 months after surgery in their motor symptoms, and all 7 patients scored more than a 50% improvement in their motor symptoms secondary to medical therapy were three patients diagnosed with dystonia as detailed in Table 2 . The characteristics of patients diagnosed with Tourette's syndrome are summarised in Table 3 .
Surgical outcomes
Surgical outcomes for these patients were assessed based on their diagnosis. Patients with a diagnosis of IPD were assessed using the United Parkinson's Disease Rating Score (UPDRS), sections III and IV, which were scored both pre-operatively and post-operatively (as Two of the patients with Tourette's Syndrome were objectively assessed using the Yale Global Tic Scoring Scale (as seen in Table 7) and Connors ADHD Score (as seen in Table 8 ).
Surgical complications
The complications encountered in our patients post-operatively are as listed in Table 9 . We had one patient with Tourette's syndrome who developed a spontaneous intracranial haemorrhage shortly following DBS (8) . Clinically, this patient complained of headaches with no new neurological deficit. The haemorrhage was found to have developed along the tract of the electrodes bilaterally. This patient did not require surgical intervention and was managed conservatively. Investigation later showed that this patient had low levels of factor XIIIA activity (8). Fenoy and Simpson studied 728 patients who underwent DBS and found symptomatic intracranial haemorrhage to occur in about 1.1% of their study sample; however, previous literature has reported risk of at 3 months after surgery. Four out of seven patients did not experience further improvement in their motor symptoms at 6, 12 and 24 months follow up after their initial improvement at 3 months. These patients also did not experience further improvement in their motor symptoms secondary to medical therapy.
The three patients diagnosed with dystonia were assessed using the Unified Dystonia Rating Scale (UDRS) and Fahn Marsden Dystonia Scale (FMDS). These patients were assessed pre-operatively and post-operatively at 3, 6, 12 and 24 months follow up. Results are shown in Table 6 .
Two out of three patients diagnosed with dystonia reported improvement in their symptoms. Both patients experienced improvement in up to 6 months follow up after surgery, after which improvement plateaued. One patient with dystonia did not experience any improvement or worsening in symptoms in the first 6 months, though this patient subsequently reported some improvement at 12 months follow up, which then remained static at 24 months follow up. Implantable Pulse generator (IPG) placed in his anterior chest wall which later became infected and required removal. The next patient who developed device-related infection was a patient who had a background of IPD, diabetes mellitus type 2 and chronic eczema. This patient presented 3 months after DBS surgery with an erythematous scalp wound. His infection did not resolve despite a course of antibiotics and required wound exploration and revision of his infection to be between a range of 0% and 15% (9) . The other patient with Tourette's Syndrome unfortunately developed an allergic reaction to the device. Due to this, the device had to be removed shortly after insertion. One of the patients with IPD who developed a device-related infection was later found to have had frequent falls at home and lack of supervision from his caretaker. Due to this, the patient developed a haematoma over the Case 2 94 60 n/a n/a n/a n/a: not available Case 2 7 n/a n/a n/a n/a n/a: not available IPG. He was then continued on another course of antibiotics. However, 3 months later, the patient returned to our attention again as he continued to have recurrent infections. He underwent a second wound re-exploration. Despite surgical management and prolonged antibiotics, the patient had a wound breakdown 18 months later. We proceeded then with removal of the implants, and the patient underwent unilateral radiofrequency ablation of the subthalmaic nucleus. The patient recovered well following this procedure. In Fenoy and Simpson's study, they found that the risk of infection was 3.1% out of which 1.4% were self-limiting and 1.3% required surgical intervention (9) . Hariz suggested in his study that in order to prevent complications, patients should be selectively matched with specific DBS procedures according to their clinical, social and cognitive manifestations, and surgeries should be performed by an experienced and meticulous surgical team (10) . Analysing most of our complications, clinical, social and cognitive circumstances of patients as per Hariz are aspects that we probably need to scrutinise in further detail when assessing their suitability for DBS.
Conclusion
DBS is still in its early years in Malaysia. Generally, we still lack large enough studies to assess the overall cost effectiveness and benefits of DBS in our community. However, literature published has clearly established the significantly positive outcomes of DBS patients which we assume theoretically will have similar outcomes in our community (11) (12) (13) (14) . We hope to be able to incorporate more neurological and psychiatric patients and establish more centres carrying out functional neurosurgery. Financial constraints are one of the main challenges we face that limit the wide use of DBS and are still yet to be overcome.
